Christie Medical Holdings has launched the third generation of VeinViewer Vision technology to provide clinicians with a non-invasive adjunct technology for various clinical treatments and procedures including IV insertions, PICC line insertions and routine venipuncture.

VeinViewer Vision uses near-infrared light and other patented technologies to project a digital image of patient vasculature directly onto the surface of the skin in real time.

The device includes advanced VeinViewer technology , which provides an improved depth of focus, a long-run battery for cordless use and an exclusive Assess imaging suite with enhanced universal and fine detail modes as well as new inverse and resize modes to serve all patient needs.

VeinViewer Vision fits in the palm of the hand and is fixed on a smaller and more mobile cart base, allowing for an optimal hands-free technique.

VeinViewer was originally launched in 2006 and is sold in more than 40 countries.